Kyle Walters
About Kyle Walters
Director, Project Management
Kyle Walters serves as Director of Project Management, leveraging over 12 years of experience in drug development. He provides strategic direction and oversight for project management activities, ensuring the successful execution and delivery of complex projects. His extensive background equips him to lead teams effectively and drive innovation in biotechnology and immuno-oncology sectors.
Education in Biomedical Toxicology and Regulatory Affairs
Kyle Walters holds an Honours Bachelor of Science degree in Biomedical Toxicology from the University of Guelph. This education provided him with a strong foundation in understanding the effects of chemicals on biological systems. Additionally, he has a Post-Graduate Certificate in Regulatory Affairs from Humber College, which equips him with the knowledge and skills to navigate the complex regulatory environment of the biotechnology industry.
Leadership at Turnstone Biologics
In his previous role as Senior Program and Alliance Manager at Turnstone Biologics, Kyle Walters led large, complex collaborations and program teams focused on developing immuno-oncology therapies. His leadership was instrumental in advancing the company’s innovative therapeutic projects, contributing to the advancement of groundbreaking treatments in cancer care.
Roles at Paraxel and Apobiologix
Kyle Walters has held leadership positions at Paraxel and Apobiologix, where he oversaw the development of oncology candidates. His work in these roles involved coordinating multidisciplinary teams and managing the progress of oncology drug development projects. These experiences honed his skills in project management and reinforced his commitment to advancing cancer therapies.
Experience in Drug Development
Kyle Walters brings over 12 years of experience in the development of drugs within biotechnology and immuno-oncology companies. His career has involved various facets of drug development, from initial research phases through to regulatory approval and market introduction. His expertise encompasses both strategic planning and tactical execution, making him a valuable asset to any drug development team.